HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2015 | 406 | 429 | 94.6% | |
| HF004 | 2016 | 505 | 540 | 93.5% | |
| HF004 | 2017 | 808 | 872 | 92.7% | |
| HF004 | 2018 | 942 | 1017 | 92.6% | |
| HF004 | 2019 | 970 | 1045 | 92.8% | |
| HF004 | 2020 | 1140 | 1216 | 93.8% | |
| HF004 | 2021 | 1292 | 1386 | 93.2% |
